MedPath

Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion

Phase 3
Completed
Conditions
Radial Artery Injury at Wrist and Hand Level
Occlusion of Artery
Vasodilation
Interventions
Registration Number
NCT03622060
Lead Sponsor
Hermina Heart Center Kemayoran
Brief Summary

A total of 600 patients undergoing coronary procedures via transradial access using 6F sheath were randomized at the end of the procedure to receive either 250-µg nicardipine or 500-µg nitroglycerin administered to the radial artery through the radial sheath before sheath removal. A continuous patent hemostasis was applied in each patient with the use of an oximetry to maintain an oxygen saturation of \>95%, measured in the finger of the accessed arm until compression device was totally removed. The primary outcome is early RAO which was evaluated by color duplex ultrasonography of the accessed arteries at the day after the radial procedure. Secondary outcome was the change of blood pressure at 2-3 minutes after drug administration. Radial artery angiogram was performed after radial sheath insertion and doppler ultrasound of the accesed radial artery was examined at the day after the procedure.

Detailed Description

Doppler ultrasound of the accessed artery was performed at the day after the radial procedure in all patients. The absence or presence of antegrade flow in the radial artery will be examined while compressing the ulnar artery as previously described.

The internal lumen radial artery diameter was evaluated by doppler ultrasound as the distance between the inner walls of the artery by personnel that are blinded to the study protocol.

Radial artery angiogram was performed soon after radial sheath insertion and the radial artery diameter was measured in AP projection in all patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
600
Inclusion Criteria
  • All patients undergoing transradial catheterization
Exclusion Criteria
  • Systolic blood pressure < 100 mmHg

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NitroglycerinNitroglycerin500 microgram intraarterial Nitroglycerin
NicardipineNitroglycerin200 microgram intraraterial Nicardipine
Primary Outcome Measures
NameTimeMethod
The absence of antegrade radial artery flow by doppler evaluation24 hour

The absence of radial artery flow by doppler evaluation

Blood pressure change2 minutes after drugs administration

Blood pressure change after drugs administration

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hermina Heart Center

🇮🇩

Jakarta Pusat, DKI Jakarta, Indonesia

© Copyright 2025. All Rights Reserved by MedPath